Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Peripheral Nervous System Diseases × Ethosuximide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Peripheral Nervous System Diseases 1 Neoplasms 1

Interventions

Glutamine 2 sagopilone 1 nicotinamide-beta-riboside 1 allantoicase 1 Vitamin D 1 Vitamin B 6 1 Vitamin B 12 1 Taxoids 1 Tadalafil 1 Sirolimus 1 Prednisolone 1 Paclitaxel 1 Minocycline 1 Metformin 1 Losartan 1 Hydroxychloroquine 1 G(M1) Ganglioside 1 Fatty Acids, Omega-3 1 Exercise 1 Everolimus 1 Etoricoxib 1 Ethosuximide 1 Epoetin Alfa 1 Dietary Supplements 1 Dexamethasone 1 Cryotherapy 1 Bortezomib 1 BID protein, human 1 Acupuncture Therapy 1 Acetylcarnitine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01278004 2016-05-26

CINE-E

Royal Marsden NHS Foundation Trust

Phase 2 Completed

Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡